• Friday, September 17, 2021
India Corona Update 
Total Fatalities 443,928
Total Cases 33,347,325
Today's Fatalities 431
Today's Cases 30,570
Pakistan Corona Update 
Total Fatalities 418,480
Total Cases 31,216,337
Today's Fatalities 3,998
Today's Cases 42,015
Sri Lanka Corona Update 
Total Fatalities 418,480
Total Cases 31,216,337
Today's Fatalities 3,998
Today's Cases 42,015
Bangladesh Corona Update 
Total Fatalities 418,480
Total Cases 31,216,337
Today's Fatalities 3,998
Today's Cases 42,015
UK Corona Update 
Total Fatalities 418,480
Total Cases 31,216,337
Today's Fatalities 3,998
Today's Cases 42,015
India corona update 
Total Fatalities 443,928
Total Cases 33,347,325
Today's Fatalities 431
Today's Cases 30,570

Business

Drug major GSK’s expansion plan to create 5,000 jobs

(Photo: VINCENZO PINTO/AFP via Getty Images)

By: Shilpa Sharma

PHARMACEUTICAL major GlaxoSmithKline (GSK) is planning to extend its facility in Stevenage, Hertfordshire that would create up to 5,000 new jobs, BBC reported.

The site is one of GSK’s two global research and development hubs, and hosts the UK’s largest work into cell and gene therapy.

The plan involves selling off a third of the site, which is expected to unlock £400 million of new investment.

The company aims to start the project in 2022. The new campus – which will sit next to GSK’s existing site at Stevenage – could ultimately deliver 100,000 square metres of new floor space for commercial life sciences research and development.

“The past 18 months has shown the UK life sciences sector at its best and the UK has recently unveiled an ambitious 10-year vision for the UK life sciences sector,” said GSK senior vice president Tony Wood.

“Our goal is for Stevenage to emerge as a top destination for medical and scientific research by the end of the decade,” he added.

The drug company, recently came under pressure from shareholders to reconfigure its businesses amid criticism over its performance.

GSK is a leading vaccine maker, but has been late to develop a jab for Covid-19. Its Covid vaccine, which is being developed with France’s Sanofi, is still undergoing trials.

However, the company is now focusing on developing new drugs and vaccines, with the GSK boss Emma Walmsley selling its consumer healthcare division, which makes big-brand products including Sensodyne and Panadol.

Eastern Eye

Related Stories

Eastern Eye

Videos

Mamta Handa on her chat show Be You, experience of…
Pranutan Bahl on Helmet, its direct-to-digital release, if Salman Khan…
Karan Nath on his journey in Bigg Boss OTT, his…